01/14/2026
Health Canada has issued a recall for Teva Octreotide for injectable suspension due to potential drug quality issues.
Full details:
Teva Canada Limited is recalling all strengths (lots listed above) of the prescription drug Octreotide as a precautionary measure due to deficiencies in Good Manufacturing Practices (GMP) identified at its foreign manufacturing site. GMPs ensure drugs meet the appropriate quality standards for their...